With 50 % of global gastric, hepatic, and esophageal cancer cases and high lung cancer incidence, China Oncology market is a unique and...

Proteus, the “smart pill” unicorn, once valued at $1.5 billion, is acquired by Otsuka for $15 million. Digital Therapeutics have a great...

In post-Covid, health professionals want more support and interactions from representatives, through a mix of virtual and in-person. This...

In a promising but risky NASH market, study shows GENFIT NIS4 easy test allows to identify patients who require treatment, without need...

Covid-19 pandemic has created roller-coaster situations for Pharma and MedTech companies. For post-covid commercial restart, life science...

How can Pharma and MedTech boost sales teams in post-covid: Adjust sales and resource expectations around scenarios Re-work incentives...

Millions of elective surgery procedures were postponed due to Covid-19, creating a backlog that will take months to clear. One way of...

According to latest HCP and consumer surveys performed in 10 countries, Covid crisis has reduced patients visits by 45%, Rep-HCP...

To shape the new normal, Pharma and Medtech companies need to push the boundaries on digital, patient-centered trial design, supply chain...

Post-M&A, achieving cross-selling synergies requires sales teams Complementarity, Connection, Capacity, Capability, Compensation and...